JHJuliette Hascoet

Juliette Hascoet

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Juliette Hascoet has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Periurethral injection of Bulkamid® for neurogenic vs. non-neurogenic female patients with stress urinary incontinence

    by Mélanie Lepretre, Brice Faurie, Camille Haudebert, Claire Richard, Alexandre Dubois, Amaury Facque, Juliette Hascoet, Benoit Peyronnet


  • Open Access

    Difficulties in Manipulating the Female Artificial Urinary Sphincter Pump: Prevalence and Management

    by Alexandre Dubois, Valentine Lethuillier, Claire Richard, Camille Haudebert, Juan Penafiel, Caroline Voiry, Magali Jezequel, Emmanuelle Emmanuel, Ouis-Paul Berthelot, Lucas Freton, et al.

    Purpose: While pump manipulation is rarely problematic in male patients with artificial urinary sphincters (AUSs), the situation may differ in female patients due to anatomical or cultural factors. This study aimed to evaluate the prevalence of difficulties in pump manipulation among female AUS patients, identify associated risk factors, and explore management strategies for this challenging issue.Methods: Data were collected from all female patients who underwent a robotic AUS implantation at a single academic center between 2014 and 2022. The primary endpoint was temporary difficulties, defined by at least one other short hospitalization to learn pump manipulation.Results: Out of the 88 female AUS patients included in the study, 20 experienced initial difficulties manipulating the pump, accounting for 22.7% of the group. Temporary difficulties were reported by 16 patients (18.2%), while 4 patients (4.5%) had their devices permanently deactivated. Surgical reoperations to reposition the pump were necessary for 5 patients, representing 5.6% of the sample. The only variables significantly associated with temporary difficulties were longer operative time (183.4 minutes vs. 159.1 minutes, P=0.04) and the overall experience of the center (32 vs. 50, P=0.04). The sole variable significantly linked to serious difficulties was the overall experience of the center (11 vs. 47, P=0.004). Although the median age and body mass index were higher in the group with temporary difficulties, these differences were not statistically significant.Conclusions: Difficulties in manipulating the pump are relatively common among female AUS patients. Most of these difficulties can be resolved through repeated patient education and careful follow-up. However, some may lead to serious complications. Raising awareness of this issue, along with ongoing patient education and meticulous follow-up, may help to minimize these consequences.


  • Long‐term outcomes of artificial urinary sphincter in female patients with spina bifida

    by Anis Gasmi, Marie‐Aimée Perrouin‐Verbe, Juliette Hascoet, Elsa Bey, Magali Jezequel, Caroline Voiry, Brigitte Perrouin‐Verbe, Xavier Gamé, Andrea Manunta, Loic Lenormand, et al.

    Aims: To report the long‐term functional outcomes of artificial urinary sphincter (AUS) implantation in female patients with spinal dysraphism and stress urinary incontinence (SUI) related to intrinsic sphincter deficiency (ISD).Methods: The charts of all spina bifida female patients with SUI due to ISD who underwent AUS (AMS 800) implantation between 2005 and 2019 at three academic departments of urology were retrospectively reviewed. Reoperation was defined as either revision or explantation of the AUS device. Reoperation‐free survival of the AUS device was estimated using the Kaplan–Meier method. Continence status as per patients' subjective assessment was categorized as follows: complete continence (no pads), improved continence, unchanged SUI or worsened SUI.Results: Twenty‐three patients were included, 69.6% were self‐catheterizing. The median follow‐up was 14 years. Median time to first reoperation was 10 years. Survival rates without reoperation were 85.9%, 41.8%, 34.6%, and 20.9% at 5, 10, 15, 20 years, respectively. Survival rates without AUS explantation were 90.7%, 66.3%, 55.2%, and 41.4% at 5, 10, 15, 20 years, respectively. None of the patients who underwent device explantation had a new AUS implanted. The only predictive factor of reoperation‐free survival was the type of spinal dysraphism (hazards ratio = 3.60 for closed vs. open dysraphism; p = .04). At last follow‐up, 17 of the 23 patients were fully continent (73.9%).Conclusion: AUS in female patients with spina bifida may be associated with satisfactory long‐term functional outcomes and a high reoperation rate. The median time to first reoperation was similar to what is reported in the male AUS literature (10 years).


  • Management of urethrocutaneous fistulae complicating sacral and perineal pressure ulcer in neurourological patients: A national multicenter study from the French‐speaking Neuro‐urology Study Group and the Neuro‐urology committee of the French Association of Urology

    by Dimitri Gambachidze, Chloë Lefèvre, Emmanuel Chartier‐Kastler, Marie‐Aimée Perrouin Verbe, Jacques Kerdraon, Guy Egon, Alexia Even, Pierre Denys, Evelyne Castel‐Lacanal, Xavier Gamé, et al.

    Purpose: To describe the epidemiologic characteristics of urethrocutaneous fistulae (UCF) in sacro‐perineal pressure ulcer (SPPU) in neurourological patients and to assess outcomes after surgical urinary diversion.Materials and Methods: Through the French‐speaking Neurourology Study Group and Association of Urology network, a retrospective multicenter study in nine major urology and physical medicine and rehabilitation (PMR) units was conducted. All patients with SPPU associated with UCF between 2000 and 2016 were included. Data concerning: sociodemography, clinical, medical and biological comorbidities, neurological and urological history, pressure ulcer characteristics, and finally urinary diversion surgery were collected. Complications and SPPU healing/relapse were assessed.Results: In all, 74 patients were included. The median age on diagnosis: 45.9 years (interquartile range [IQR], 38.7‐53.4) and median follow‐up: 15.1 months (IQR, 5.7‐48.8). A psychiatric disorder was the most frequent comorbidity (44.6%). Only 59.5% and 50% had regular PMR and urologic follow‐up, respectively. Seventy‐one patients (95.9%) underwent urinary diversion surgery. Among those, relapse occurred in 15 (21.1%) at the end of the follow‐up. The diversion was noncontinent in 85.9%. The major complications rate was 26.8%. A total of 30 late complications in 21 patients were reported. The most frequent was obstructive pyelonephritis (n = 9). All of the patients who underwent surgical diversion without cystectomy (n = 5) developed a pyocyst. Finally, the pressure ulcer healing rate when patients underwent both urinary diversion and pressure ulcer surgery was 74.4%.Conclusions: Our retrospective data suggest that UCF complicating SPPU is a rare and severe pathology. The combination of radical urinary diversion with cystectomy and pressure ulcer surgery should be performed as often as possible.


  • Robot-assisted bladder neck artificial urinary sphincter implantation in male patients with neurogenic stress urinary incontinence: A multicenter study

    by F. Encatassamy, J. Hascoët, T. Brierre, A. Manunta, L. Le Normand, X. Gamé, B. Peyronnet, M-A. Perrouin-Verbe